Analysis of HLA A*02 Association with Vaccine Efficacy in the RV144 HIV-1 Vaccine Trial

The RV144 HIV-1 vaccine trial demonstrated partial efficacy of 31% against HIV-1 infection. Studies into possible correlates of protection found that antibodies specific to the V1 and V2 (V1/V2) region of envelope correlated inversely with infection risk and that viruses isolated from trial particip...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Gartland, Andrew J., Li, Sue, McNevin, John, Tomaras, Georgia D., Gottardo, Raphael, Janes, Holly, Fong, Youyi, Morris, Daryl, Geraghty, Daniel E., Kijak, Gustavo H., Edlefsen, Paul T., Frahm, Nicole, Larsen, Brendan B., Tovanabutra, Sodsai, Sanders-Buell, Eric, deCamp, Allan C., Magaret, Craig A., Ahmed, Hasan, Goodridge, Jodie P., Chen, Lennie, Konopa, Philip, Nariya, Snehal, Stoddard, Julia N., Wong, Kim, Zhao, Hong, Deng, Wenjie, Maust, Brandon S., Bose, Meera, Howell, Shana, Bates, Adam, Lazzaro, Michelle, O'Sullivan, Annemarie, Lei, Esther, Bradfield, Andrea, Ibitamuno, Grace, Assawadarachai, Vatcharain, O'Connell, Robert J., deSouza, Mark S., Nitayaphan, Sorachai, Rerks-Ngarm, Supachai, Robb, Merlin L., Sidney, John, Sette, Alessandro, Zolla-Pazner, Susan, Montefiori, David, McElrath, M. Juliana, Mullins, James I., Kim, Jerome H., Gilbert, Peter B., Hertz, Tomer
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2014
Assuntos:
Vaccines and Antiviral Agents
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4135964/
https://ncbi.nlm.nih.gov/pubmed/24829343
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.01164-14
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados